Source |
Code |
Name |
Case count |
Share of cases (%) |
PURCH |
PURCH_ATC(H05BA01) |
Calcitonin (salmon synthetic) |
2714 |
|
OUTPAT |
OUTPAT_ICD10(E2109) |
Other primary hyperparathyroidism |
2400 |
|
OUTPAT |
OUTPAT_ICD10(E210) |
Primary hyperparathyroidism |
1987 |
|
INPAT |
INPAT_ICD10(E2109) |
Other primary hyperparathyroidism |
1434 |
|
OUTPAT |
OUTPAT_ICD10(E213) |
Hyperparathyroidism, unspecified |
997 |
|
INPAT |
INPAT_ICD10(E210) |
Primary hyperparathyroidism |
817 |
|
PURCH |
PURCH_ATC(H05BX01) |
Cinacalcet |
719 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E2109) |
Other primary hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
639 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E210) |
Primary hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
617 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E213) |
Hyperparathyroidism, unspecified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
585 |
|
INPAT |
INPAT_ICD10(E213) |
Hyperparathyroidism, unspecified |
469 |
|
OUTPAT |
OUTPAT_ICD10(E212) |
Other hyperparathyroidism |
398 |
|
OUTPAT |
OUTPAT_ICD10(E211) |
Secondary hyperparathyroidism, not elsewhere classified |
222 |
|
INPAT |
INPAT_ICD10(E212) |
Other hyperparathyroidism |
174 |
|
PURCH |
PURCH_ATC(H05BX02) |
Paricalcitol |
143 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E212) |
Other hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
132 |
|
INPAT |
INPAT_ICD10(E211) |
Secondary hyperparathyroidism, not elsewhere classified |
108 |
|
INPAT |
INPAT_ICD9(2520A) |
Hyperparathyroidism |
95 |
|
INPAT |
INPAT_ICD8(25200) |
Diseases of parathyroid gland, Hyperparathyroidism |
79 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E211) |
Secondary hyperparathyroidism, not elsewhere classified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
40 |
|
DEATH |
DEATH_ICD10(E210) |
Primary hyperparathyroidism |
9 |
|